AI & ChatGPT searches , social queriess for LINSITINIB

Search references for LINSITINIB. Phrases containing LINSITINIB

See searches and references containing LINSITINIB!

AI searches containing LINSITINIB

LINSITINIB

  • Linsitinib

    • Chemical compound

    Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like

    Linsitinib

    Linsitinib

    Linsitinib

  • Insulin

    • Peptide hormone

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Insulin

    Insulin

    Insulin

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Cerebrolysin

    Cerebrolysin

  • Ponazuril

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Ponazuril

    Ponazuril

    Ponazuril

  • Amitriptyline

    • Tricyclic antidepressant

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Insulin-like growth factor 1 receptor

    • Cell receptor protein found in humans

    microRNA miR-7. Hypothalamic–pituitary–somatic axis Insulin receptor Linsitinib, an inhibitor of IGF-1R in clinical trials for cancer treatment GRCh38:

    Insulin-like growth factor 1 receptor

    Insulin-like growth factor 1 receptor

    Insulin-like_growth_factor_1_receptor

  • Receptor activity-modifying protein

    • Protein family

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Receptor activity-modifying protein

    Receptor_activity-modifying_protein

  • Dexamethasone

    • Corticosteroid medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • IGF-1 LR3

    • Synthetic protein

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    IGF-1 LR3

    IGF-1_LR3

  • RAMP2

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    RAMP2

    RAMP2

    RAMP2

  • Tyrosine kinase

    • Enzyme

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Vascular endothelial growth factor

    • Protein involved in blood vessel growth

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Integrin

    Integrin

    Integrin

  • Insulin-like growth factor 1

    • Protein found in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • ACD856

    • TrkA and TrkB positive modulator

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    ACD856

    ACD856

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Wnt signaling pathway

    Wnt_signaling_pathway

  • SPV-400

    • Pharmaceutical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    SPV-400

    SPV-400

  • IGFBP3

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    IGFBP3

    IGFBP3

    IGFBP3

  • Testosterone

    • Primary male sex hormone

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Testosterone

    Testosterone

    Testosterone

  • Dihexa

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dihexa

    Dihexa

    Dihexa

  • Imatinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Imatinib

    Imatinib

    Imatinib

  • Growth factor receptor inhibitor

    • Class of compounds

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Growth factor receptor inhibitor

    Growth_factor_receptor_inhibitor

  • HER2

    • Mammalian protein found in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    HER2

    HER2

    HER2

  • PDGFRB

    • Protein-coding gene in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    PDGFRB

    PDGFRB

    PDGFRB

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Growth factor

    Growth_factor

  • Trastuzumab deruxtecan

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Osimertinib

    Osimertinib

    Osimertinib

  • Low-affinity nerve growth factor receptor

    • Human protein-coding gene

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Low-affinity nerve growth factor receptor

    Low-affinity nerve growth factor receptor

    Low-affinity_nerve_growth_factor_receptor

  • Fibroblast growth factor receptor 3

    • Gene involved in the most common form of dwarfism

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fibroblast growth factor receptor 3

    Fibroblast growth factor receptor 3

    Fibroblast_growth_factor_receptor_3

  • Bevacizumab

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Bevacizumab

    Bevacizumab

  • Dasatinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dasatinib

    Dasatinib

    Dasatinib

  • Pazopanib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Pazopanib

    Pazopanib

  • Vemurafenib

    • Targeted cancer drug

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Vemurafenib

    Vemurafenib

    Vemurafenib

  • Testosterone (medication)

    • Medication and naturally occurring steroid hormone

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Testosterone (medication)

    Testosterone (medication)

    Testosterone_(medication)

  • Filgrastim

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Filgrastim

    Filgrastim

    Filgrastim

  • Trastuzumab

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Dehydroepiandrosterone

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Cetuximab

    • Pharmaceutical drug

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Cetuximab

    Cetuximab

    Cetuximab

  • Signaling peptide receptor

    • Cell surface receptors

    Mecasermin rinfabate Antagonists BMS-754807 S661 S961 Kinase inhibitors Linsitinib Antibodies Xentuzumab (against IGF-1 and IGF-2) Agonists Kisspeptin (kisspeptin-54

    Signaling peptide receptor

    Signaling_peptide_receptor

  • Ponatinib

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Ponatinib

    Ponatinib

    Ponatinib

  • Tropoflavin

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Tropoflavin

    Tropoflavin

    Tropoflavin

  • Renalase

    • Mammalian protein found in Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Renalase

    Renalase

    Renalase

  • Lenvatinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Mirvetuximab soravtansine

    • Pharmaceutical drug

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Mirvetuximab soravtansine

    Mirvetuximab soravtansine

    Mirvetuximab_soravtansine

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Trametinib

    • Anticancer medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Trametinib

    Trametinib

    Trametinib

  • Epidermal growth factor receptor

    • Transmembrane protein

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Nerve growth factor

    • Mammalian protein found in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • List of signaling peptide/protein receptor modulators

    • Mecasermin rinfabate Antagonists: BMS-754807 S661 S961 Kinase inhibitors: Linsitinib Antibodies: Xentuzumab (against IGF-1 and IGF-2) Agonists: Kisspeptin

    List of signaling peptide/protein receptor modulators

    List_of_signaling_peptide/protein_receptor_modulators

  • Pralsetinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Pralsetinib

    Pralsetinib

  • Trastuzumab emtansine

    • Pharmaceutical drug

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Trastuzumab emtansine

    Trastuzumab emtansine

    Trastuzumab_emtansine

  • Receptor tyrosine kinase

    • Class of enzymes

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Fibroblast growth factor

    • Family of proteins involved in anatomical development

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fibroblast growth factor

    Fibroblast_growth_factor

  • IGFBP4

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    IGFBP4

    IGFBP4

    IGFBP4

  • Angiopoietin 1

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Angiopoietin 1

    Angiopoietin 1

    Angiopoietin_1

  • Fibroblast growth factor 23

    • Protein found in humans

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fibroblast growth factor 23

    Fibroblast growth factor 23

    Fibroblast_growth_factor_23

  • Fruquintinib

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fruquintinib

    Fruquintinib

    Fruquintinib

  • Pegfilgrastim

    • Monoclonal antibody

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Pegfilgrastim

    Pegfilgrastim

  • Repotrectinib

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Neurotrophic factors

    • Family of biomolecules

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Neurotrophic factors

    Neurotrophic_factors

  • Sorafenib

    • Cancer treatment medicine

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Sorafenib

    Sorafenib

    Sorafenib

  • Hepatocyte growth factor

    • Mammalian protein found in Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Olmutinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Olmutinib

    Olmutinib

    Olmutinib

  • Dehydroepiandrosterone sulfate

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • Platelet-derived growth factor

    • Signaling glycoprotein regulating cell proliferation

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Platelet-derived growth factor

    Platelet-derived growth factor

    Platelet-derived_growth_factor

  • Cabozantinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Cabozantinib

    Cabozantinib

    Cabozantinib

  • Insulin-like growth factor

    • Proteins similar to insulin that stimulate cell proliferation

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Insulin-like growth factor

    Insulin-like growth factor

    Insulin-like_growth_factor

  • Gefitinib

    • Medication used for cancer

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Gefitinib

    Gefitinib

    Gefitinib

  • RAMP1

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    RAMP1

    RAMP1

    RAMP1

  • Epidermal growth factor

    • Protein that stimulates cell division and differentiation

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Epidermal growth factor

    Epidermal growth factor

    Epidermal_growth_factor

  • Encorafenib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Encorafenib

    Encorafenib

    Encorafenib

  • VEGF receptor

    • Protein family

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    VEGF receptor

    VEGF receptor

    VEGF_receptor

  • Erlotinib

    • Medication for treatment of non-small-cell lung cancer

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Erlotinib

    Erlotinib

    Erlotinib

  • Dabrafenib

    • Anti-cancer medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Dabrafenib

    Dabrafenib

    Dabrafenib

  • Regorafenib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Regorafenib

    Regorafenib

  • Placental growth factor

    • Protein-coding gene in the species Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Placental growth factor

    Placental growth factor

    Placental_growth_factor

  • Sunitinib

    • Cancer medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Sunitinib

    Sunitinib

    Sunitinib

  • Nintedanib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Nintedanib

    Nintedanib

    Nintedanib

  • Hemopoietic growth factor

    • Class of proteins

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Hemopoietic growth factor

    Hemopoietic_growth_factor

  • Axitinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Axitinib

    Axitinib

    Axitinib

  • Amivantamab

    • Monoclonal antibody

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Amivantamab

    Amivantamab

    Amivantamab

  • Alectinib

    • ALK inhibitor for treatment of non-small-cell lung cancer

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Alectinib

    Alectinib

    Alectinib

  • Amivantamab/hyaluronidase

    • Medication

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Amivantamab/hyaluronidase

    Amivantamab/hyaluronidase

  • KIT (gene)

    • Mammalian protein and protein-coding gene

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    KIT (gene)

    KIT (gene)

    KIT_(gene)

  • FGF5

    • Mammalian protein found in Homo sapiens

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    FGF5

    FGF5

    FGF5

  • Neurotrophin

    • Family of proteins

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Neurotrophin

    Neurotrophin

    Neurotrophin

  • Fibroblast growth factor 2

    • Growth factor and signaling protein otherwise known as FGF2

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Fibroblast growth factor 2

    Fibroblast growth factor 2

    Fibroblast_growth_factor_2

  • GFRα

    • Protein family

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    GFRα

    GFRα

  • Prasterone

    • Medical usage of the prasterone compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Prasterone

    Prasterone

    Prasterone

  • Transforming growth factor

    • Biomarker indicative of breast cancer patients' prognosis

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Transforming growth factor

    Transforming_growth_factor

  • OSI Pharmaceuticals

    • American pharmaceutical company

    subsequently developed by OSI in conjunction with Genentech. Companies portal Linsitinib (OSI-906), an inhibitor of IGF-1R in clinical trials for cancer treatment

    OSI Pharmaceuticals

    OSI_Pharmaceuticals

  • Selumetinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Selumetinib

    Selumetinib

    Selumetinib

  • Faricimab

    • Medication for macular degeneration

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Faricimab

    Faricimab

    Faricimab

  • Platelet-derived growth factor receptor

    • Cell surface receptors

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Platelet-derived growth factor receptor

    Platelet-derived growth factor receptor

    Platelet-derived_growth_factor_receptor

  • Binimetinib

    • Chemical compound

    Insulin Mecasermin Mecasermin rinfabate Kinase inhibitors: BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab

    Binimetinib

    Binimetinib

    Binimetinib

AI & ChatGPT searchs for online references containing LINSITINIB

LINSITINIB

AI search references containing LINSITINIB

LINSITINIB

AI search queriess for Facebook and twitter posts, hashtags with LINSITINIB

LINSITINIB

Follow users with usernames @LINSITINIB or posting hashtags containing #LINSITINIB

LINSITINIB

Online names & meanings

  • YEHUDIT

    • Female

    Hebrew

    YEHUDIT

    Variant spelling of Hebrew Yehuwdiyth, YEHUDIT means "Jewess" or "praised."

  • Mateen

    • Boy/Male

    Afghan, Arabic, Australian, Iranian, Muslim, Pashtun, Sindhi

    Mateen

    Strong; Patient; Solid; Constant; Tough; Substantive; Firm

  • Roopesh

    • Boy/Male

    Bengali, Hindu, Indian, Malayalam, Marathi, Tamil, Telugu

    Roopesh

    Beauty of Lord Shiva

  • Dhanvanth | தநவஂத

    • Boy/Male

    Tamil

    Dhanvanth | தநவஂத

    Wealthy

  • Miqdam |

    • Boy/Male

    Muslim

    Miqdam |

    In the forefront of battle

  • Tanseem | تنسیم

    • Girl/Female

    Muslim

    Tanseem | تنسیم

    Salute of paradise

  • Tuley

    • Surname or Lastname

    English (Yorkshire)

    Tuley

    English (Yorkshire) : unexplained.

  • Pierpont

    • Boy/Male

    French Latin

    Pierpont

    Lives by the stone bridge.

  • Banarasi

    • Boy/Male

    Hindu, Indian

    Banarasi

    Sacred; Belonging to Benaras

  • Shubham

    • Boy/Male

    Bengali, Hindu, Indian, Marathi, Marwadi, Sanskrit

    Shubham

    Care; Winner; Religious; Auspicious; Positive

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with LINSITINIB

LINSITINIB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing LINSITINIB

LINSITINIB

AI searchs for Acronyms & meanings containing LINSITINIB

LINSITINIB

AI searches, Indeed job searches and job offers containing LINSITINIB

Other words and meanings similar to

LINSITINIB

AI search in online dictionary sources & meanings containing LINSITINIB

LINSITINIB